New bifunctional Prodrugs with cleavable linker for targeted tumor therapy (ADC)
Scientists at the University of Göttingen in Germany developed new and highly potent drugs with cleavable chemical linkers to develop tumor specific antibodies for selective tumor therapy (ADC). The soluble prodrugs are activated into highly cytotoxic drugs only in targeted tumor cells.
Further information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Dr. Jens-Peter Horst
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
All latest news from the category: Technology Offerings
Artificial Intelligence for Improved Baltic Sea Protection
Innovative Monitoring Concept for the Eckernförde Bay Receives State Funding. Artificial intelligence will help improve the monitoring of the ecological condition of the Eckernförde Bay in the future. The linking…